Guardian Pharmacy Services acquires Mercury Pharmacy Services in Washington, expanding its presence in the Pacific Northwest and meeting growing demand for LTC support.
Amid tariff uncertainty and its possibly adverse implications for inflation and corporate earnings, the major US equity indices, after massive rallies post-April lows, are witnessing sellers come out at/near resistance.
SAIC stock down after reporting Q1 2026 earnings. Sales up 2%, EPS misses estimates. CEO notes progress against growth strategy. Lower revenue and EPS outlook.
BioNTech and Bristol Myers Squibb will co-develop BNT327 for solid tumors in a $1.5 billion deal with potential milestones totaling up to $7.6 billion.
Separately, Regeneron on Monday also announced positive interim data from its ongoing Phase 2 trial investigating novel combinations of semaglutide and Trevogrumab with or without garetosmab for the treatment of obesity.
